Codes / ICD10CM / H35.381

H35.381 Toxic maculopathy, right eye

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Toxic Maculopathy, Right Eye (H35.381)

Name of the Condition

  • Toxic Maculopathy, Right Eye

Summary

Toxic maculopathy is a condition affecting the macula, the central part of the retina responsible for sharp central vision. It results from exposure to substances that damage retinal tissue, potentially leading to vision impairment. When limited to the right eye, the condition may present with unilateral symptoms and requires targeted evaluation of the affected eye.

Causes

The condition is caused by exposure to toxic substances or medications that harm the macula. Common culprits include certain drugs (e.g., antimalarials, tamoxifen) and environmental toxins. The toxic effects disrupt retinal cells, leading to functional and structural changes in the right eye.

Risk Factors

  • Long-term use of medications known to affect the retina.
  • High cumulative doses of retinal-toxic drugs.
  • Pre-existing retinal conditions or genetic susceptibility.
  • Age-related changes in retinal metabolism.

Symptoms

  • Blurred or distorted central vision in the right eye.
  • Difficulty reading or seeing fine details with the right eye.
  • Changes in color perception in the right eye.
  • Dark spots or blind areas in the visual field of the right eye.

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing and dilated fundoscopy of the right eye. Optical coherence tomography (OCT) assesses retinal layers, while fluorescein angiography may detect vascular changes. A detailed patient history of medication or toxin exposure is critical.

Treatment Options

  • Discontinuation or substitution of the offending medication, if applicable.
  • Regular monitoring of retinal health in the right eye.
  • Vision rehabilitation therapies tailored to the affected eye.
  • Management of underlying conditions contributing to toxicity.

Prognosis and Follow-Up

Prognosis depends on early identification and removal of the toxic agent. With prompt intervention, some visual function may recover. Follow-up includes regular eye examinations to monitor for progression or improvement, with frequency determined by clinical severity.

Complications

  • Permanent vision loss in the right eye if damage is severe.
  • Progression to bilateral involvement if exposure continues.
  • Reduced quality of life due to visual impairment.

Lifestyle & Prevention

  • Avoid known retinal-toxic medications when possible.
  • Use protective measures to limit environmental toxin exposure.
  • Maintain regular eye examinations, especially with high-risk medication use.
  • Report new visual symptoms promptly to healthcare providers.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden changes in vision, blurred or distorted vision, or new blind spots in the right eye. Early evaluation is crucial to minimize potential damage.

Tips for Medical Coders

Document the laterality (right eye) clearly in the medical record. Ensure the diagnosis aligns with clinical findings and exposure history. Code H35.381 is specific to toxic maculopathy affecting the right eye; verify no bilateral involvement before assigning this code.

Book a walkthrough

H35.381 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.